Insider Trading29 Jun 2026, 03:16 pm
Novelix Pharmaceuticals Closes Trading Window for Insider Trading
AI Summary
Novelix Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their relatives. This closure will be effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. The company is adhering to SEBI (Prohibition of Insider Trading) Regulations, 2015, and its internal code of conduct. All designated individuals are prohibited from trading in the company's securities during this period to prevent potential insider trading.
Key Highlights
- Trading window closed for designated persons and relatives.
- Closure effective from July 1, 2026.
- Period lasts until 48 hours post Q1 FY27 results declaration.
- Aims to comply with SEBI Insider Trading Regulations.
- Prohibits trading in company securities during closure.
Price Impact
More from TRIMURTHI